Last Updated:
Name Designation Appointment Date Status
Sankar Venkitachalam Iyer

Appointed as Director since June 2011

Director 16-Jun-2011 Current
Name Designation Appointment Date Status
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Deveshkumar Hariharprasad Shukla

Appointed as Director since June 2011

Director 16-Jun-2011 Current
Sitalakshmy Sankar

Appointed as Director since June 2011

Director 16-Jun-2011 Current

People Timeline

Explore the timeline of key personnel in Sitasans Pharmachem Private Limited's leadership journey.

Loading...
Contact Details
  • Address 90/301 Alamela Apartments 4Th Main Malleswaram, Bangalore Karnataka, 560003, India
  • Telephone Upgrade
  • Email Upgrade
Frequently Asked Questions
How can I contact Sitasans Pharmachem Private Limited?
You can contact Sitasans Pharmachem Private Limited through their registered address at 90/301 Alamela Apartments 4Th Main Malleswaram, Bangalore Karnataka, 560003, India, or via their website at sitasans.com. Social media links are also provided where applicable.
Who are the current directors of Sitasans Pharmachem Private Limited?
The current directors of Sitasans Pharmachem Private Limited are listed above in the "Current Directors & Signatories" section. You can view their names, designations, and appointment dates.
  • SITALAKSHMY SANKAR
  • DEVESHKUMAR HARIHARPRASAD SHUKLA
  • SANKAR VENKITACHALAM IYER
How can I access past director details?
Past director details are available under the "Past Directors & Signatories" tab. You may need to upgrade your subscription to view detailed information.
Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available